AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
18:16
DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)
24:50
Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari
20:14
How to Approach to Ovarian Cancer from Community Oncology Perspective
23:25
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
26:19
Palliative Care Management in Cancer | Onc Brothers
17:57
From Approval to Practice: Managing Side Effects of Antibody Drug Conjugates (ADC) in Cancer
23:22
The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)
18:29